|
|
Post by myocat on Apr 11, 2016 8:08:06 GMT -5
|
|
|
|
Post by sla55 on Apr 11, 2016 8:08:38 GMT -5
investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=964413— Analyst Call Scheduled for April 19, 2016 at 5:00 PM EDT — VALENCIA, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host an analyst call for the investment community to learn about the company's general commercialization strategy in the US for Afrezza® (insulin human) Inhalation Powder. MannKind has recently assumed responsibility for the worldwide development and commercialization of Afrezza from Sanofi and will begin to distribute Afrezza in the third quarter. Until that time, Sanofi will continue to distribute Afrezza from its existing inventory of product. To participate in the live call by telephone, please dial (888) 224-7957 or (303) 223-4394 and use the participant passcode: 21809665. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (800) 633-8284 or (402) 977-9140 and use the participant passcode: 21809665. A replay will also be available on MannKind's website for 14 days. MannKind's Chief Executive Officer, Matthew J. Pfeffer, and Chief Commercial Officer, Michael E. Castagna, will discuss the strategic commercial approach for Afrezza in the U.S. The discussion will include plans for sales and marketing of Afrezza, including reimbursement and access programs for patients, marketing programs and expansion plans. Timelines for relaunch activities will also be discussed. MannKind plans to report quarterly earnings on May 9, 2016 and will discuss financial results of the first quarter of 2016 and future financial projections for the remainder of 2016 and beyond at that time.
|
|
|
|
Post by kbrion77 on Apr 11, 2016 8:25:25 GMT -5
This is either going to be a great or rough couple of weeks. Best of luck to everyone.
|
|
|
|
Post by tayl5 on Apr 11, 2016 8:25:54 GMT -5
Good news to start the week! This will give the shorts who bought all the "MannKind is doomed" articles last week something to think about.
|
|
|
|
Post by tayl5 on Apr 11, 2016 8:31:23 GMT -5
This is either going to be a great or rough couple of weeks. Best of luck to everyone. Considering the default assumption in the absence of news is bankruptcy, I see this as a very positive development. Management wouldn't hold the call if they didn't have good things to discuss. Of course, shorts will bash whatever Matt says but at least they can't say there isn't a plan. |
|
|
|
Post by agedhippie on Apr 11, 2016 8:37:18 GMT -5
Management wouldn't hold the call if they didn't have good things to discuss. Of course, shorts will bash whatever Matt says but at least they can't say there isn't a plan. I am not expecting much beyond a timeline. For me the far more important thing is that they are keeping us informed which is a huge improvement. |
|
alexer
Lab Rat
Posts: 49 
Sentiment: Long
|
Post by alexer on Apr 11, 2016 8:38:43 GMT -5
MNKD seems to be very aggressive so far when it comes to Afrezza, glad to see they're in full control of marketing. Great news to start the week!
|
|
|
|
Post by mnholdem on Apr 11, 2016 9:13:34 GMT -5
Good news to start the week! This will give the shorts who bought all the "MannKind is doomed" articles last week something to think about. I also think there was an important omission that definitely should not be overlooked in this PR which states that, at the scheduled analyst conference call, Matt & Mike will be discussing commercialization plans for the U.S.
The fact that there is no mention, whatsoever, of marketing outside the U.S. indicates to me that ex-U.S. distribution agreements are currently being negotiated and cannot be mentioned if they are under non-disclosure agreement(s).
If pps got a 20% pop today over a simple announcement like this morning's PR, imagine what will happen to share price when(if) MannKind announces that it has signed agreements for the international (regional) distribution of Afrezza?
100%-200% squeeze or more?  
|
|
|
|
Post by jerrys on Apr 11, 2016 11:33:37 GMT -5
But will they discuss the key issues -- insurance reimbursement, black box, warning of lung damage, COPD, cancer, spirometry, etc. Mr. Castagna had an interview published today on "fircepharma," but there's simply no substance:
"I know people would say it's a no-brainer--it's inhaled versus an injection--but you've got to have that emotional connection that people are dealing with this disease every single day."
"Insurance companies are also important, he said, noting that MannKind is already working to remove managed care barriers and he is pleased with the progress."
"Diabetes educators will play a role as well. Usually nurses, they will be employed by MannKind, Castagna said, and work similarly to medical science liaisons."
Why do they need an "emotional connection"? What kind of "emotional connection"? How will they develop it? How will that overcome insurance and all the rest? And everyone already realizes the importance of insurance companies, but how are "barriers" being removed and exactly what progress have they made? And "diabetes educators"? Educate about what? It's supposed to be simple right -- just "inhale" -- but now they need to hire educators? What kind of return on investment are these educators supposed to generate?
I really don't believe any idea what endos and type 1s are interested in most. They sound like someone just reading out of a marketing textbook. |
|
|
|
Post by peppy on Apr 11, 2016 11:38:59 GMT -5
But will they discuss the key issues -- insurance reimbursement, black box, warning of lung damage, COPD, cancer, spirometry, etc. Mr. Castagna had an interview published today on "fircepharma," but there's simply no substance:
"I know people would say it's a no-brainer--it's inhaled versus an injection--but you've got to have that emotional connection that people are dealing with this disease every single day."
"Insurance companies are also important, he said, noting that MannKind is already working to remove managed care barriers and he is pleased with the progress."
"Diabetes educators will play a role as well. Usually nurses, they will be employed by MannKind, Castagna said, and work similarly to medical science liaisons."
Why do they need an "emotional connection"? What kind of "emotional connection"? How will they develop it? How will that overcome insurance and all the rest? And everyone already realizes the importance of insurance companies, but how are "barriers" being removed and exactly what progress have they made? And "diabetes educators"? Educate about what? It's supposed to be simple right -- just "inhale" -- but now they need to hire educators? What kind of return on investment are these educators supposed to generate?
I really don't believe any idea what endos and type 1s are interested in most. They sound like someone just reading out of a marketing textbook. enough said |
|
|
|
Post by nylefty on Apr 11, 2016 11:55:12 GMT -5
What is a Certified Diabetes Educator?
A Certified Diabetes Educator® (CDE®) is a health professional who possesses comprehensive knowledge of and experience in prediabetes, diabetes prevention, and management. The CDE® educates and supports people affected by diabetes to understand and manage the condition. A CDE® promotes self-management to achieve individualized behavioral and treatment goals that optimize health outcomes.
The Certification Examination for Diabetes Educators (Examination) is designed and intended for health professionals who have responsibilities that include the direct provision of diabetes self-management education (DSME), as defined by NCBDE. www.ncbde.org/certification_info/what-is-a-cde/
|
|
|
|
Post by LosingMyBullishness on Apr 11, 2016 13:17:35 GMT -5
What is a Certified Diabetes Educator?
A Certified Diabetes Educator® (CDE®) is a health professional who possesses comprehensive knowledge of and experience in prediabetes, diabetes prevention, and management. The CDE® educates and supports people affected by diabetes to understand and manage the condition. A CDE® promotes self-management to achieve individualized behavioral and treatment goals that optimize health outcomes.
The Certification Examination for Diabetes Educators (Examination) is designed and intended for health professionals who have responsibilities that include the direct provision of diabetes self-management education (DSME), as defined by NCBDE. www.ncbde.org/certification_info/what-is-a-cde/ Please don't take this as a pessimistic statement but do you think that such people are in general less prejudiced and super conservative than endos? |
|
|
|
Post by LosingMyBullishness on Apr 11, 2016 13:23:03 GMT -5
What is a Certified Diabetes Educator?
A Certified Diabetes Educator® (CDE®) is a health professional who possesses comprehensive knowledge of and experience in prediabetes, diabetes prevention, and management. The CDE® educates and supports people affected by diabetes to understand and manage the condition. A CDE® promotes self-management to achieve individualized behavioral and treatment goals that optimize health outcomes.
The Certification Examination for Diabetes Educators (Examination) is designed and intended for health professionals who have responsibilities that include the direct provision of diabetes self-management education (DSME), as defined by NCBDE. www.ncbde.org/certification_info/what-is-a-cde/ Please don't take this as a pessimistic statement but do you think that such people are in general less prejudiced and super conservative than endos? When I read what you wrote I had the idea that the standard care for diabetics is hammered into these people with all the does and do nots. |
|
|
|
Post by nylefty on Apr 11, 2016 13:25:53 GMT -5
What is a Certified Diabetes Educator?
A Certified Diabetes Educator® (CDE®) is a health professional who possesses comprehensive knowledge of and experience in prediabetes, diabetes prevention, and management. The CDE® educates and supports people affected by diabetes to understand and manage the condition. A CDE® promotes self-management to achieve individualized behavioral and treatment goals that optimize health outcomes.
The Certification Examination for Diabetes Educators (Examination) is designed and intended for health professionals who have responsibilities that include the direct provision of diabetes self-management education (DSME), as defined by NCBDE. www.ncbde.org/certification_info/what-is-a-cde/ Please don't take this as a pessimistic statement but do you think that such people are in general less prejudiced and super conservative than endos? I assume that the CDEs hired by MannKind will be as enthusiastic about Afrezza as the CDE who wrote the enthusiastic article that was posted on the Cleveland Clinic's website. |
|
|
|
Post by peppy on Apr 11, 2016 13:26:19 GMT -5
What is a Certified Diabetes Educator?
A Certified Diabetes Educator® (CDE®) is a health professional who possesses comprehensive knowledge of and experience in prediabetes, diabetes prevention, and management. The CDE® educates and supports people affected by diabetes to understand and manage the condition. A CDE® promotes self-management to achieve individualized behavioral and treatment goals that optimize health outcomes.
The Certification Examination for Diabetes Educators (Examination) is designed and intended for health professionals who have responsibilities that include the direct provision of diabetes self-management education (DSME), as defined by NCBDE. www.ncbde.org/certification_info/what-is-a-cde/ Please don't take this as a pessimistic statement but do you think that such people are in general less prejudiced and super conservative than endos? I have come to believe that is vernacular for "uninformed or minimally informed." |
|
